CVS Health Corporation closed at $90.44 on October 15, 2026, marking a single-session gain of 3.27%. The advance pushed the stock's seven-day performance into positive territory at 2.85%, offering some relief to investors who had watched shares slide in recent weeks.
Despite the short-term recovery, CVS carries a 30-day loss of 5.35%, indicating that Thursday's move has not fully offset the pressure the stock faced over the prior month. The company's market capitalization stood at $111.97 billion as of the close.
CVS Health operates across pharmacy benefits management, retail pharmacy, and health insurance segments, making it one of the larger integrated health services companies by market value in the United States. Thursday's session reflected broader interest in the shares without reversing the stock's negative 30-day trend.
Traders and market observers noted the divergence between the stock's near-term gains and its longer-term monthly decline as a key dynamic heading into the remainder of the trading week.
